MedPath

NMPA Approvals

Chinese National Medical Products Administration approved drug approval numbers and registration information

National Medical Products Administration
China
166,322 Approvals
Showing 164601 to 164620 of 166,322 approvalsPage 8231 of 8317

Cefprozil for Suspension

Approval Number: 国药准字H20103106
Registration: Sep 27, 2019

桑菊感冒合剂

Approval Number: 国药准字Z44020471
Registration: Sep 27, 2019

健儿清解液

Approval Number: 国药准字Z44023404
Registration: Sep 27, 2019

Ceftazidime for Injection

Approval Number: 国药准字H20043380
Registration: Sep 27, 2019

Metformin Hydrochloride Enteric-Coated Capsules

Approval Number: 国药准字H20094132
Registration: Sep 27, 2019

Cefoxitin Sodium for Injection

Approval Number: 国药准字H20057503
Registration: Sep 27, 2019

妇科调经颗粒

Approval Number: 国药准字Z20026678
Registration: Sep 27, 2019

腰息痛胶囊

Approval Number: 国药准字Z44020478
Registration: Sep 27, 2019

Cycloserine Capsules

Approval Number: H20140983
Registration: Sep 27, 2019

Calcium Oyster Shell Effervescent Tablets

Approval Number: 国药准字H44024533
Registration: Sep 27, 2019

Cefuroxime Sodium for Injection

Approval Number: 国药准字H20040254
Registration: Sep 27, 2019

Yigan Jiedu Jiaonang

Approval Number: 国药准字Z44020480
Registration: Sep 27, 2019

Lincomycin Hydrochloride Injection

Approval Number: 国药准字H35020360
Registration: Sep 27, 2019

Cefprozil for Suspension

Approval Number: 国药准字H20103107
Registration: Sep 27, 2019

藿香正气水

Approval Number: 国药准字Z44020482
Registration: Sep 27, 2019

Ceftazidime for Injection

Approval Number: 国药准字H20043381
Registration: Sep 27, 2019

Fingolimod Hydrochloride Capsules

Approval Number: 国药准字J20190024
Registration: Sep 27, 2019

Imiquimod

Approval Number: 国药准字H20040282
Registration: Sep 27, 2019

妇科调经颗粒

Approval Number: 国药准字Z20073205
Registration: Sep 27, 2019

感冒清胶囊

Approval Number: 国药准字Z44020467
Registration: Sep 27, 2019

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.